🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

3 Super Cheap Stocks Under $22 to Buy in September

Published 2021-09-09, 12:25 p/m
3 Super Cheap Stocks Under $22 to Buy in September

Cheap stocks are always a good buy. That’s because their downside is limited and upside could be immense – the definition of a great investment. That said, most investors have two different definitions of “cheap stocks.” In an attempt to please everyone, here are my top two picks for stocks trading under $20 that are also fundamentally undervalued.

Cheap stock #1 WELL Health (TSX:WELL) is always a top pick for growth investors. This little-known health-tech startup has delivered a 7,000% return since going public in 2016! Now, it’s a mature tech stock trading at an attractive valuation.

This year the company expects to generate $400 million in revenue. Meanwhile, its market value is roughly $1.6 billion. In other words, the stock is trading at a forward price-to-revenue ratio of four, which is unbelievably low for a software company.

WELL Health’s key growth driver is acquisitions, the perfect strategy for the deeply fragmented healthcare market. Recent acquisitions have helped the company launch online pharmacies, telehealth services, and private clinics across North America. Backed by a Hong Kong billionaire, WELL Health’s consolidation of the trillion-dollar healthcare sector is just getting started.

Keep an eye on this $7.8 stock.

Cheap stock #2 Alaris Equity Partners Income Trust (TSX:AD.UN) (formerly Alaris Royalty), is another cheap stock worth looking into. The company occupies a unique niche — preferred equity investor in private businesses. In other words, it’s an investment company that targets small- and mid-sized companies and buys up preferred shares to extract consistent cash flow.

The company’s target is 13% to 15%. Meanwhile, the stock trades at $18.3 and offers a 6.8% dividend yield. The stock also trades at a price-to-earnings ratio of 6.5, which implies an earnings yield of 15.4%!

Those yields and valuation metrics seem almost too good to be true. This is why it’s worth noting some of the risks. Alaris is vulnerable to business cycles. A sudden spike in interest rates or unexpected recession could plunge many of its portfolio companies into chaos.

However, I believe the current valuation has priced in that risk. This is why this cheap stock deserves a spot on your watch list.

Cheap stock #3 Trading at $21 a share and 15.6 times earnings, Aecon Group (TSX:ARE) is the final pick on this list. The company offers construction services for large-scale infrastructure projects. That’s a sector of the economy it seems everyone can agree is likely to boom.

The company blew past analyst estimates in its most recent quarter. Adjusted EBIDTA came in 15% higher than anticipated at $61 million. Now, it’s targeting $4 billion in revenue this year. It also has a backlog of projects worth $6 billion for the years ahead.

Aecon seems to offer robust earnings, revenue visibility, and stable growth. That’s why it deserves a spot on your watch list for cheap stocks this year.

The post 3 Super Cheap Stocks Under $22 to Buy in September appeared first on The Motley Fool Canada.

Fool contributor Vishesh Raisinghani owns shares of WELL Health Technologies Corp. The Motley Fool recommends Alaris Equity Partners Income Trust.

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.